Evidence map›Paper›PMID 28550439›Full record

Trial reportObesity surgery2017

Baseline Anthropometric and Metabolic Parameters Correlate with Weight Loss in Women 1-Year After Laparoscopic Roux-En-Y Gastric Bypass.

Arnaud Sans, Laurent Bailly, Rodolphe Anty, Igor Sielezenef, Jean Gugenheim, Albert Tran, Philippe Gual, Antonio Iannelli

Erratum issued Registry-linked trialAbstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Obesity surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT02820285 (Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH), which is not on this map. Cited by 15 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 6 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02820285 nacompletednot on this map

Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH

TypeinterventionalSponsorCentre Hospitalier Universitaire de NiceRan2013 to 2016Enrolled148ConditionsNon Alcoholic Fatty Liver DiseaseArmsEvaluation of the staging of fibrosis liver, Determine the expression level of semaphorin, Determination of the composition of immunity cells
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 6 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Observational
  10. Article
  11. Review
  12. Article
  13. Observational
  14. Observational
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Arnaud SansDepartment of Digestive Surgery, CHU Timone, Marseille, France.
Laurent BaillyUniversité Côte d'Azur, LAMHESS, Nice, France.
Rodolphe AntyDigestive Unit, Archet 2 Hospital, University Hospital of Nice, 06202, Nice, France.
Igor SielezenefDepartment of Digestive Surgery, CHU Timone, Marseille, France.
Jean GugenheimDigestive Unit, Archet 2 Hospital, University Hospital of Nice, 06202, Nice, France.
Albert TranDigestive Unit, Archet 2 Hospital, University Hospital of Nice, 06202, Nice, France.
Philippe GualInserm, U1065, Team 8 "Hepatic complications of obesity", 06204, Nice, France.
Antonio IannelliDigestive Unit, Archet 2 Hospital, University Hospital of Nice, 06202, Nice, France. iannelli.a@chu-nice.fr.ORCID 0000-0002-0119-7744
Inserm · FRUniversité Côte d'Azur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn this study, we explored in a prospective cohort of morbidly obese women undergoing laparoscopic Roux-en-Y gastric bypass (LRYGP) correlations between baseline anthropometrics, metabolic parameters, resting energy expenditure (REE), body composition, and 1-year % excess body mass index loss (%EBMIL). We also investigated risk factors for insufficient %EBMIL.

methodsOne hundred three consecutive women were prospectively evaluated at baseline (age 40.6 ± 11.2, weight 113.9 kg ± 15.3, BMI 43.3 ± 4.9 kg/m

resultsAt 1 year, mean weight loss was 39.8 kg ± 11.7 and mean EBMIL was 15.2 kg/m

conclusionLRYGB has beneficial effects on clinical, biological parameters, and body composition. Increasing the proportion of FFM on total BW and REE/BW is associated with better results in terms of weight loss. Baseline glucose level may be helpful in identifying poor responders to LRYGBP.

trial registrationNCT02820285y ( https://clinicaltrials.gov/ct2/show/NCT02820285?term=Characterization+of+Immune+Semaphorin+in+Non-Alcoholic+Fatty+Liver+Disease+and+NASH&rank=1 ).

Indexed as

Body Weights and MeasuresGastric BypassAdultBlood GlucoseBody Mass IndexEnergy MetabolismFemaleFollow-Up StudiesHumansInsulin ResistanceLaparoscopyMiddle AgedObesity, MorbidPreoperative PeriodPrognosisTime FactorsBlood GlucoseBody compositionFailureFat free massMordid obesityRoux-en-Y gastric bypassWeight loss

Identifiers

PMID28550439
OpenAlexW2620289621

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.